Tag: Novo Nordisk A/S
US election reaction and stock movements
Healthcare stocks rose, driven by Siemens Healthineers, Novo NordiskHealth care stocks in the Stoxx 600 index rose 2.8%…
The US FDA to reconsider the decision to block the compounded version of Lilly’s weight loss drug
Eli Lilly and Company, a Pharmaceutical company headquartered in Alcobendas, Madrid, Spain.Cristina Arias Closing | Getty ImagesThe US…
Novo and Eli contender Zealand Pharma target ‘next generation’ obesity drugs
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a…
Blockbuster weight loss drug supplier hit by trade shutdown
Eli Lilly & Co. injection pen. Zepbound, March 28, 2024.Bloomberg Bloomberg Getty ImagesAs a port strike stretching from…
East Coast ports strike, ILA trade union shuts down billions in trade
A shipping container sits in Newark Harbor on September 30, 2024 as seen from New York City. The…
Novo Nordisk’s CEO testifies in the Senate about the price of weight loss drugs
Novo NordiskTop executives faced a Senate grilling on Tuesday over the high prices of the company's weight loss…
Eli Lilly is releasing a new, cheaper weight loss drug
The Zepbound injection pen, Eli Lilly's weight loss drug, is shown in New York City on December 11,…
Eli Lilly’s weight loss drug reduces the risk of developing diabetes in a trial
Eli Lilly A popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in…
What’s next for Biden’s Medicare drug price negotiations
US President Joe Biden and Vice President Kamala Harris walk together, during a Medicare drug price negotiation event,…
Medicare released prices for the first 10 drugs subject to negotiation
Activists protest the price of prescription drugs in front of the US Department of Health and Human Services…
Ro launches GLP-1 insurance coverage checker
Zoom In IconThe arrow points outwardDirect-to-consumer health startup Ro launched a new free tool Tuesday to help patients…
Yuri Khodjamirian Theme ETFs on weight loss drugs, AI and more
Weight loss drugs and artificial intelligence have dominated the headlines, with investors betting that stocks in the two…